Definitive Contract HHSN268201000029C
Award Date
7/30/10
Potential Completion Date
10/30/17
Potential Value
$95M
Federal Agency
National Heart Lung and Blood Institute
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...
The National Heart, Lung and Blood Institute of the Department of Health and Human Services National Institutes of Health awarded a $954,000 firm fixed price delivery order to The Broad Institute, Inc. under the Centralized Omic REsource for TOPMed (CORE) multiple award indefinite delivery/indefinite quantity contract vehicle. This delivery order is for whole genome sequencing services to support somatic mutation identification in the Genotype-Tissue Expression (GTEx) program. No set-aside...
This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including genomic...
This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...
This federal contract award was issued by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The $2,343,147.64 firm fixed price contract is a delivery order under the Centralized Omic REsource for TOPMed (CORE) indefinite delivery vehicle (IDV), which has a $500 million ceiling to support the Trans-Omics for Precision Medicine initiative through genomics data...
This is a $24,910,368.70 firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to The Broad Institute, Inc., a non-profit research organization. The contract is for task areas 2, 3, and 4 of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) initiative, which supports large-scale genomics research. The contract has an ultimate completion date of...
This is a $36,406,715.12 Firm Fixed Price Delivery Order awarded to The Broad Institute, Inc., a non-profit research organization, by the National Heart, Lung and Blood Institute (NHLBI). The contract is for the fifth year of the Centralized Omics Resource (CORE) program, which supports genomics data generation, analysis, and management services for the Trans-Omics for Precision Medicine (TOPMed) initiative. The Broad Institute has a larger $500 million Indefinite Delivery Contract with NHLBI...
This is a $8,473,939.55 firm fixed-price delivery order awarded to The Broad Institute, Inc. by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The work is performed in support of the Centralized Omics Resource (CORE) program, which provides genomics data generation, analysis, and management services for the Trans-Omics for Precision Medicine (TOPMed) initiative. The Broad Institute is the prime contractor on this task order, which...
This is a $5,105,063.80 delivery order contract awarded to The Broad Institute, Inc., a non-profit biomedical and genomic research organization, by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute. The contract is part of the Centralized Omic REsource for TOPMed (CORE) master indefinite delivery, indefinite quantity (IDIQ) contract, which supports the Trans-Omics for Precision Medicine (TOPMed) program. The contract does not have a...
This firm fixed-price purchase order for $108,629.18 was awarded by the National Institute of Environmental Health Sciences, a civilian agency, to The Broad Institute, Inc. for whole exome sequencing services. The contract has no set-aside designation, reflecting The Broad Institute's competitive capabilities in advanced genomic research and data analysis services. The Broad Institute has performed similar work for other federal agencies like the Centers for Disease Control and Prevention,...